Akero Therapeutics Inc (AKRO) Insider Trading
- $51,054,850.25
- $162,086,685.97
- June 20, 2025
- Andrew Cheng
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 20, 2025 | VP | 875 | $54.59 | Sell | $47,766.25 | |
June 18, 2025 | CTO | 848 | $54.84 | Sell | $46,504.32 | |
June 18, 2025 | CEO | 6,620 | $54.84 | Sell | $363,040.80 | |
June 18, 2025 | Insider | 1,129 | $54.84 | Sell | $61,914.36 | |
June 18, 2025 | CFO | 1,634 | $54.84 | Sell | $89,608.56 | |
June 18, 2025 | Insider | 1,633 | $54.84 | Sell | $89,553.72 | |
June 18, 2025 | COO | 1,453 | $54.84 | Sell | $79,682.52 | |
June 16, 2025 | VP | 2,000 | $54.14 | Sell | $108,280.00 | |
June 16, 2025 | Insider | 10,000 | $54.23 | Sell | $542,300.00 | |
June 10, 2025 | COO | 2,493 | $53.99 | Sell | $134,597.07 | |
June 10, 2025 | Insider | 2,358 | $54.00 | Sell | $127,332.00 | |
June 10, 2025 | CFO | 2,804 | $53.99 | Sell | $151,387.96 | |
June 10, 2025 | VP | 919 | $54.00 | Sell | $49,626.00 | |
June 10, 2025 | Insider | 2,803 | $54.00 | Sell | $151,362.00 | |
June 10, 2025 | CEO | 37,837 | $54.05 | Sell | $2,045,089.85 | |
June 6, 2025 | Insider | 25,000 | $55.04 | Sell | $1,376,000.00 | |
June 5, 2025 | Insider | 12,500 | $53.49 | Sell | $668,625.00 | |
June 2, 2025 | VP | 4,000 | $50.31 | Sell | $201,240.00 | |
May 22, 2025 | VP | 4,000 | $50.00 | Sell | $200,000.00 | |
May 15, 2025 | Insider | 10,000 | $39.30 | Sell | $393,000.00 | |
May 12, 2025 | CEO | 30,000 | $41.48 | Sell | $1,244,400.00 | |
May 7, 2025 | VP | 8,000 | $42.49 | Sell | $339,920.00 | |
May 6, 2025 | Insider | 12,500 | $43.43 | Sell | $542,875.00 | |
April 24, 2025 | Insider | 6,250 | $41.03 | Sell | $256,437.50 | |
April 15, 2025 | Insider | 9,073 | $37.91 | Sell | $343,957.43 | |
April 10, 2025 | CEO | 30,000 | $35.23 | Sell | $1,056,900.00 | |
April 7, 2025 | Insider | 6,250 | $35.88 | Sell | $224,250.00 | |
March 27, 2025 | Director | 50,000 | $43.55 | Buy | $2,177,500.00 | |
March 25, 2025 | Director | 91,309 | $44.75 | Buy | $4,086,077.75 | |
March 17, 2025 | Insider | 10,000 | $44.76 | Sell | $447,600.00 | |
March 12, 2025 | CFO | 676 | $44.88 | Sell | $30,338.88 | |
March 12, 2025 | COO | 607 | $44.88 | Sell | $27,242.16 | |
March 12, 2025 | Insider | 614 | $44.88 | Sell | $27,556.32 | |
March 12, 2025 | CEO | 1,738 | $44.88 | Sell | $78,001.44 | |
March 10, 2025 | CEO | 30,000 | $41.77 | Sell | $1,253,100.00 | |
March 5, 2025 | Insider | 12,500 | $44.53 | Sell | $556,625.00 | |
March 4, 2025 | COO | 50,000 | $44.86 | Sell | $2,243,000.00 | |
March 3, 2025 | VP | 1,000 | $48.09 | Sell | $48,090.00 | |
Feb. 18, 2025 | Insider | 10,000 | $49.87 | Sell | $498,700.00 | |
Feb. 10, 2025 | CEO | 30,000 | $52.73 | Sell | $1,581,900.00 | |
Feb. 5, 2025 | Insider | 18,750 | $56.51 | Sell | $1,059,562.50 | |
Feb. 3, 2025 | COO | 10,000 | $53.81 | Sell | $538,100.00 | |
Jan. 27, 2025 | CEO | 30,000 | $54.90 | Sell | $1,647,000.00 | |
Jan. 27, 2025 | Insider | 31,250 | $55.77 | Sell | $1,742,812.50 | |
Jan. 27, 2025 | VP | 5,000 | $57.03 | Sell | $285,150.00 | |
Jan. 2, 2025 | COO | 10,000 | $28.03 | Sell | $280,300.00 | |
Dec. 16, 2024 | Insider | 9,074 | $29.11 | Sell | $264,144.14 | |
Dec. 16, 2024 | VP | 1,000 | $29.13 | Sell | $29,130.00 | |
Dec. 10, 2024 | COO | 2,503 | $30.79 | Sell | $77,067.37 | |
Dec. 10, 2024 | VP | 925 | $30.79 | Sell | $28,480.75 |
Insiders are both buying and selling Akero Therapeutics Inc stock.
The insider traders at Akero Therapeutics Inc are: Andrew Cheng, Catriona Yale, Jonathan Young, William Richard White, Timothy Rolph, Patrick Lamy, G. Walmsley Graham, Seth Loring Harrison, Global Strategic Fund I Venbio, Kevin Bitterman, Scott A Gangloff, Skorpios Trust, Aaron Royston, Tomas J. Heyman, and Apple Tree Partners Iv, L.P.
The most active insider trader at Akero Therapeutics Inc is Andrew Cheng with 37 trades.
Skorpios Trust has sold the most Akero Therapeutics Inc stock with a total value of $142,332,000.00.
Apple Tree Partners Iv, L.P. has bought the most Akero Therapeutics Inc stock with a total value of $29,880,000.00.
The most recent insider trade for Akero Therapeutics Inc was on June 20, 2025.
The single biggest insider buy for Akero Therapeutics Inc was from Apple Tree Partners Iv, L.P. with a total value of $14,940,000.00 on July 10, 2020.
The single biggest insider sell for Akero Therapeutics Inc was from Skorpios Trust with a total value of $71,166,000.00 on Dec. 1, 2022.